Climate Change Data

Torrent Pharmaceuticals Limited

Climate Impact & Sustainability Data (2019-20, 2020-04 to 2021-03, 2021-04 to 2022-03, 2022-04 to 2023-03, 2023-04 to 2024-03)

Reporting Period: 2019-20

Environmental Metrics

ESG Focus Areas

  • Community Healthcare
  • Sanitation & Hygiene
  • Education & Knowledge Enhancement
  • Social Care & Concern
  • Environment, Health & Safety

Environmental Achievements

  • Achieved major reduction in waste generation
  • Utilization of waste as an alternative fuel
  • Conservation of energy to reduce environmental impact
  • Disposed-off more than 60% high calorific value hazardous waste for Co-processing / Pre-processing in cement industries
  • Efforts to use canteen food waste and biological waste from ETP for generation of bio gas

Social Achievements

  • Swadhar community healthcare facility renamed Sumangal and integrated into Rangtarang hospital complex
  • Sumangal operates with enhanced scope including specialized consultations
  • 1,00,311 patients benefited from Sumangal
  • Donations amounting to ` 10.74 crores to various organisations
  • Donated ` 20.00 crores to PM – CARES Fund

Governance Achievements

  • Re-appointment of Shri Samir Mehta as Executive Chairman
  • Appointment of Shri Jinesh Shah as Director and Whole-time Director
  • All the recommendations of all the Committees were accepted by the Board

Climate Goals & Targets

Environmental Challenges

  • Supply chain disruptions due to COVID-19 pandemic
  • Downward pricing pressure from increasing competition
  • Stringent government regulations and regulatory compliance leading to higher regulatory costs
  • Potential API and generic shortages
  • Postponement of new product launches due to COVID-19
Mitigation Strategies
  • Risk mitigation plan including reduction on dependency on one region or country for input raw materials
  • De-risking the product by developing capabilities to manufacture the product at different locations
  • Embracing digitization in day to day operations and remote working
  • Careful market research for selection of new products, detailed project planning and continuous monitoring
  • Careful patent analysis prior to development & launch of the generic products and strategy of early settlement with the patent holders

Supply Chain Management

Responsible Procurement
  • Suppliers Code of Conduct
  • Evaluation of the EHS resources and their compliance by suppliers and vendors

Climate-Related Risks & Opportunities

Reporting Period: 2020-04 to 2021-03

Environmental Metrics

Total Carbon Emissions:107,736.95 tCO2e/year
Total Energy Consumption:120K+ MWh/year

ESG Focus Areas

  • Climate change and energy management
  • Emissions
  • Waste and water management
  • Employee engagement, safety and well-being
  • Equality
  • Ethics and business integrity
  • Adherence to laws
  • Information security
  • Community development

Environmental Achievements

  • CO2 emission reduction by 3%
  • NOX emission reduction by 11%
  • SOX emission reduction by 11%
  • Waste disposal reduction by 1%
  • Groundwater use reduction by 7%
  • Over 55% of waste produced being recycled
  • ~87% of water consumed being recycled

Social Achievements

  • Impacted 71,000 lives through CSR programmes
  • REACH initiative benefiting several villages
  • Organised regular safety trainings and conduct audits to ensure a safe workplace for all
  • Fostered a zero discrimination policy

Governance Achievements

  • Strong Board oversight
  • Robust internal controls
  • Compliance management systems and continuous monitoring
  • Independent assessments and audits

Climate Goals & Targets

Environmental Challenges

  • Pandemic-induced uncertainties and related economic slowdown
  • Lack of new approvals in the US due to pending re-inspection of facilities by USFDA
  • Supply chain disruptions due to COVID-19
  • Intensification of competition and threat of new entrants
  • Price erosion
  • Risk of price regulation
  • Challenges and uncertainties inherent in innovation and development of new products
  • Non-compliance with regulations
  • Geo-political, economic and currency fluctuation risks
Mitigation Strategies
  • Chronic-based business model, patient centricity and business continuity processes
  • Upgrading quality systems at facilities
  • Filing double-digit ANDAs every year
  • Working on increasing cost competitiveness
  • Continuous portfolio optimisation and various cost initiatives to sustain margins
  • Strong governance mechanism based on ‘zero tolerance to non-compliance’
  • Careful market research for selection of new products, detailed project planning and continuous monitoring
  • Seeking suitable alliances with partners
  • Foreign Exchange Risk Management policy
  • Alternate sourcing, higher inventory levels, vertical manufacturing integration, digital interventions for remote working
  • Alternate manufacturing sites
  • Loan License Manufacturing (LLM) and P2P

Supply Chain Management

Responsible Procurement
  • Supplier code of conduct
  • Capability-building programmes for suppliers

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: International Integrated Reporting (IR) Framework of the International Integrated Reporting Council (IIRC)

Certifications: ISO 14001, ISO 45001, ISO 50001

Reporting Period: 2021-04 to 2022-03

Environmental Metrics

Total Carbon Emissions:126,926 tCO2e/year
Scope 1 Emissions:28,009 tCO2e/year
Scope 2 Emissions:98,916 tCO2e/year
Renewable Energy Share:2%
Total Energy Consumption:8,55,880 GJ/year
Water Consumption:0.966 Mn m3/year
Waste Generated:8,669.66 tons/year

ESG Focus Areas

  • Environment
  • Social
  • Governance

Environmental Achievements

  • 36% increase in renewable energy generation
  • 48% water recycled
  • 78% waste recycled
  • 53% reduction in landfill waste disposal compared to previous year
  • Reduced 21% Scope 1 and Scope 2 emissions from 2020 levels

Social Achievements

  • Launched REACH program, extending to 1000 villages, screening 7,500+ malnourished children
  • Provided hygiene kits to 14,000+ adolescent girls
  • Launched Shiksha Setu Phase III to enhance primary education
  • 4.86+ lakhs man-hour trainings conducted
  • 85% employees upskilled

Governance Achievements

  • Adopted a structured ESG framework & strategy based on international standards
  • Implemented a robust vigil mechanism to report unethical behavior
  • Established a Corporate Social Responsibility and Sustainability Committee

Climate Goals & Targets

Long-term Goals:
  • Net zero emissions
Medium-term Goals:
  • Reduce freshwater withdrawal by 25%
  • Promote Circular Economy through recycling of 100% of Non-Hazardous waste
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Pricing pressures in the US base business
  • Lack of new launches pending re-inspection of facilities by USFDA
  • Intensification of competition in Germany
  • Muted market growth recovery in Germany
  • Supply chain disruptions
Mitigation Strategies
  • Initiated cost optimization measures
  • Completed CAPAs and submitted closure report to USFDA
  • Strengthened cost and price competitiveness in Germany
  • Developed alternate sourcing strategies
  • Implemented various ‘business continuity’ measures

Supply Chain Management

Supplier Audits: 100% critical suppliers assessed on ESG Parameters

Responsible Procurement
  • Supplier Code of Conduct
  • ESG parameters integrated into supplier assessment

Climate-Related Risks & Opportunities

Opportunities
  • Renewable energy
  • Energy efficiency

Reporting Standards

Frameworks Used: GRI, SASB, UN SDGs

Certifications: ISO 14001:2015, ISO 45001:2018, ISO 50001

UN Sustainable Development Goals

  • Goal 3
  • Goal 4
  • Goal 5
  • Goal 6
  • Goal 7
  • Goal 8
  • Goal 9
  • Goal 12
  • Goal 13

Initiatives contribute to various SDGs through community healthcare, education, women's empowerment, environmental stewardship, and responsible business practices.

Sustainable Products & Innovation

  • Biodegradable sanitary napkins
  • Complex generics
  • NDDS products

Reporting Period: 2022-04 to 2023-03

Environmental Metrics

Total Carbon Emissions:801.95 TJ (tCO2e)
Scope 1 Emissions:97,111 tCO2e
Scope 2 Emissions:25,063 tCO2e
Renewable Energy Share:2.54%
Water Consumption:1.046 mn m3
Waste Generated:6,625.02 tons

ESG Focus Areas

  • Sustainable practices
  • Responsible resource management
  • Shared value creation for stakeholders

Environmental Achievements

  • 3.74% Reduction in Scope 1 and Scope 2 Emissions
  • 6.3% Reduction in energy consumption
  • 55% of total rainwater harvesting potential achieved
  • Zero waste landfill at several facilities
  • 64% of total waste generated being recycled

Social Achievements

  • Contribution of ₹26 crores towards CSR initiatives
  • 44,800+ children screened for malnourishment and anaemia
  • 100% employees obtained training on health and safety
  • 4,196 new employees onboarded
  • Initiatives for women's health and sanitation
  • Establishment of a dedicated hospital for children and adults providing free critical care services

Governance Achievements

  • 100% Compliance to Code of Conduct, resulting in zero conflict of interest
  • 6 out of 10 Board Members are Independent Directors
  • 7 out of 10 are Non-Executive Directors

Climate Goals & Targets

Long-term Goals:
  • Net zero emissions
Medium-term Goals:
  • Reduce carbon footprint by 21% from 2019-20 levels by 2024-25
  • Achieve 15% women representation in the workforce by 2024-25
Short-term Goals:
  • Increase rainwater harvesting by 100% and reduce freshwater withdrawal by 30% by 2024-25

Environmental Challenges

  • Intense competition and threat of new entrants
  • Commoditization of products
  • Pricing control risks
  • R&D risks
  • Compliance risks
  • Quality and product liability risks
  • Risks of operating in overseas markets
  • Business continuity risks
  • Environmental, social, and governance risks
  • Information technology risks
Mitigation Strategies
  • Specialty-driven approach and building big brands
  • Innovative products
  • Portfolio optimization and cost initiatives
  • Careful market research, project planning, and continuous monitoring
  • Strong governance mechanism and zero tolerance for non-compliance
  • Robust pharmacovigilance function
  • Due diligence and hedging currency exposures
  • Diversifying supplier base and alternative sourcing strategies
  • Adopting a structured ESG framework and strategy
  • Robust IT framework and information security policy

Supply Chain Management

Responsible Procurement
  • Supplier sustainability requirements
  • ESG factors considered in vendor selection

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: Integrated Reporting Framework (IIRC), Global Reporting Initiatives (GRI), UN Sustainable Development Goals (UN SDGs)

Certifications: ISO 14001, ISO 45001, ISO 50001

Sustainable Products & Innovation

  • Methylcobalamin nasal spray
  • Various FDCs and NDDS initiatives

Reporting Period: 2023-04 to 2024-03

Environmental Metrics

Scope 1 Emissions:15,294 tCO2e
Scope 2 Emissions:76,268 tCO2e
Renewable Energy Share:30.2%
Total Energy Consumption:846.81 TJ
Water Consumption:1.082 mn m3
Waste Generated:5,684.27 tons

ESG Focus Areas

  • Product Quality and Safety
  • Innovation: Strengthening R&D Pipeline
  • Water and Wastewater Management
  • Energy Efficiency and Renewable Energy
  • Employee Engagement, Safety and Well-being
  • Equality
  • Ethics and Business Integrity
  • Adherence to Laws

Environmental Achievements

  • 24.3% Reduction in non-renewable energy consumption
  • 1.70 MW Solar energy capacity installed
  • 25.1% Reduction in carbon footprint
  • 30.2% Share of renewable energy in total energy consumption
  • 6,766 MT tonnes Waste recycled and reused

Social Achievements

  • 649 Employees on-boarded (Net)
  • 5.20+ Lacs Manhours of training imparted
  • 100% Employees obtained training on health and safety
  • 31,000+ children Screened through the medical camps
  • 1,87,000+ OPDs Carried out across 11 centres

Governance Achievements

  • 100% Compliance to Code of Conduct, resulting in zero conflict of interest

Climate Goals & Targets

Short-term Goals:
  • Reduce freshwater withdrawal by 25%

Environmental Challenges

  • Intense competition and threat of new entrants
  • Regulatory agencies regulating prices
  • Uncertainty of clinical outcomes, regulatory approvals, and commercial success in R&D
  • Varying regulatory landscapes across geographies
  • Geopolitical, economic, and currency fluctuation risks in overseas markets
  • Evolving ESG risks
  • Risk of loss or disclosure of trade secrets
  • Potential disruption or failure of operations due to unexpected events
Mitigation Strategies
  • Specialty-driven approach and building robust brands
  • Innovative products in diverse dosage forms
  • Continuous portfolio optimisation and cost initiatives
  • Thorough market research, detailed project planning, and continuous monitoring in R&D
  • Robust governance mechanism and zero tolerance for non-compliance
  • Due diligence during new investments and hedging currency exposures
  • Adopting a structured ESG framework and strategy
  • Complete IT Framework with ISMS policies, multi-layer control mechanism, and vulnerability assessments

Supply Chain Management

Responsible Procurement
  • Evaluation and selection of vendors based on EHS resources and compliance

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: Integrated Reporting Framework, GRI, UN SDGs

Certifications: ISO 14001, ISO 45001, ISO 50001

Third-party Assurance: Grant Thornton Bharat LLP